(Q41733355)

8 October 2017

1 reference

title

Current treatment recommendations in antiarrhythmic therapy (English)

1 reference

8 October 2017

author

Harry J. G. M. Crijns

series ordinal

3

object named as

Crijns HJ

1 reference

8 October 2017

Isabelle C Van Gelder

series ordinal

1

object named as

Van Gelder IC

1 reference

8 October 2017

Brügemann J

2

1 reference

8 October 2017

publication date

1 March 1998

1 reference

8 October 2017

1 reference

8 October 2017

volume

55

1 reference

8 October 2017

issue

3

1 reference

8 October 2017

page(s)

331-346

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199855030-00002

8 October 2017

exact match

0 references

cites work

Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest

1 reference

12 December 2020

Concentration response relationships of amiodarone and desethylamiodarone

1 reference

12 December 2020

1 reference

12 December 2020

Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings

1 reference

12 December 2020

Improving survival for patients with atrial fibrillation and advanced heart failure

1 reference

12 December 2020

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

1 reference

12 December 2020

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

12 December 2020

The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-II.

1 reference

12 December 2020

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

1 reference

12 December 2020

Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.

1 reference

12 December 2020

Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation

1 reference

12 December 2020

Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators

1 reference

12 December 2020

The hazards of using type 1C antiarrhythmic drugs for the treatment of paroxysmal atrial fibrillation

1 reference

12 December 2020

1 reference

12 December 2020

Idiopathic ventricular tachycardia and fibrillation

1 reference

12 December 2020

Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (the CASCADE study)

1 reference

12 December 2020

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

1 reference

12 December 2020

Controlled trial of sotalol for one year after myocardial infarction

1 reference

12 December 2020

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

1 reference

12 December 2020

Significance of classifying antiarrhythmic actions since the cardiac arrhythmia suppression trial

1 reference

12 December 2020

An evaluation of DC shock treatment of atrial arrhythmias

1 reference

12 December 2020

Comparative electrophysiologic effects of intravenous amiodarone and desethylamiodarone in dogs: evidence for clinically relevant activity of the metabolite

1 reference

12 December 2020

Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter

1 reference

12 December 2020

Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators

1 reference

12 December 2020

Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter

1 reference

12 December 2020

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

12 December 2020

Clinical challenge. II. Management of recent onset atrial fibrillation. PAFIT-2 Investigators

1 reference

12 December 2020

Cardioversion of atrial fibrillation in the elderly

1 reference

12 December 2020

Mechanisms and risk factors for proarrhythmia with type Ia compared with Ic antiarrhythmic drug therapy

1 reference

12 December 2020

Survival with oral d-Sotalol in patients with left ventricular dysfunction after myocardial infarction: Rationale, design, and methods (the SWORD trial)

1 reference

12 December 2020

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

1 reference

12 December 2020

Long-term follow-up after sustained monomorphic ventricular tachycardia: Causes, pump failure, and empiric antiarrhythmic therapy that modify survival

1 reference

12 December 2020

Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study

1 reference

12 December 2020

Effect of amiodarone on conduction and refractoriness of the His-Purkinje system in the human heart

1 reference

12 December 2020

Ibutilide, a new compound with potent class III antiarrhythmic activity, activates a slow inward Na+ current in guinea pig ventricular cells

1 reference

12 December 2020

Electrophysiologic effects of desethylamiodarone, an active metabolite of amiodarone: comparison with amiodarone during chronic administration in rabbits

1 reference

12 December 2020

Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator

1 reference

12 December 2020

Adverse effects of low dose amiodarone: a meta-analysis

1 reference

12 December 2020

1 reference

12 December 2020

The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm

1 reference

12 December 2020

Ventricular premature complexes and sudden death after myocardial infarction

1 reference

12 December 2020

Determinants of predicted efficacy of antiarrhythmic drugs in the electrophysiologic study versus electrocardiographic monitoring trial. The ESVEM Investigators

1 reference

12 December 2020

Ibutilide, a methanesulfonanilide antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells. Concentration-, time-, voltage-, and use-dependent effects.

1 reference

12 December 2020

Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group

1 reference

12 December 2020

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

12 December 2020

Verapamil reduces tachycardia-induced electrical remodeling of the atria

1 reference

12 December 2020

Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens

1 reference

12 December 2020

Effect of propranolol after acute myocardial infarction in patients with congestive heart failure

1 reference

12 December 2020

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

1 reference

12 December 2020

The automatic implantable cardioverter defibrillator: Efficacy, complications and survival in patients with malignant ventricular arrhythmias

1 reference

12 December 2020

Atrial flutter can be terminated by a class III antiarrhythmic drug but not by a class IC drug

1 reference

12 December 2020

Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials

1 reference

12 December 2020

Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. A randomized study.

1 reference

12 December 2020

The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology

1 reference

12 December 2020

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

1 reference

12 December 2020

Mechanism of action potential prolongation by RP 58866 and its active enantiomer, terikalant. Block of the rapidly activating delayed rectifier K+ current, IKr.

1 reference

12 December 2020

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

1 reference

12 December 2020

Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)

1 reference

12 December 2020

Antiarrhythmic drugs versus implantable defibrillators: the need for a randomized controlled study

1 reference

12 December 2020

Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia

1 reference

12 December 2020

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

1 reference

12 December 2020

Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil

1 reference

12 December 2020

Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA).

1 reference

12 December 2020

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

1 reference

12 December 2020

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

12 December 2020

Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group

1 reference

12 December 2020

Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients

1 reference

12 December 2020

Adverse effects of amiodarone at low dose: plus ça change

1 reference

12 December 2020

Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction. SSSD Investigators. Spanish Study on Sudden Death

1 reference

12 December 2020

The historical development, cellular electrophysiology and pharmacology of amiodarone

1 reference

12 December 2020

Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators

1 reference

12 December 2020

Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial

1 reference

12 December 2020

A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias

1 reference

12 December 2020

A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs

1 reference

12 December 2020

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

1 reference

12 December 2020

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

12 December 2020

The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis

1 reference

12 December 2020

Electrical remodeling in atrial fibrillation. Time course and mechanisms

1 reference

12 December 2020

Comparison of binding to rapidly activating delayed rectifier K+ channel, IKr, and effects on myocardial refractoriness for class III antiarrhythmic agents

1 reference

12 December 2020

Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators

1 reference

12 December 2020

The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations.

1 reference

12 December 2020

Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation

1 reference

12 December 2020

10.2165/00003495-199855030-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

8 October 2017

1023509344

0 references

1 reference